volume 29, issue 2, P213-218 2014
DOI: 10.3109/02688697.2014.976173
View full text
|
Sign up to set email alerts
|
Share

Abstract: SRS appears to offer a reasonable rate of facial nerve preservation and tumor control for patients with small-to-medium-sized FNS. Considering the published outcomes achieved with resection, RS may be the preferred first-line treatment for these tumors.

Search citation statements

Order By: Relevance

Citation Types

0
4
0

Paper Sections

0
0
0
0
0

Publication Types

0
0
0
0

Relationship

0
0

Authors

Journals